2016 editions
- December 2016
Joao Incio on mechanisms to explain why obesity promotes cancer. - November 2016
Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer. - October 2016
Ruth Muschel on a new target for treatments for colorectal cancer. - September 2016
Freddie Hamdy on the effectiveness of treatments for prostate cancer. - August 2016
Moshe Oren discusses the effects of the microenvironment on cancer cells. - July 2016
Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer. - June 2016
Key advances in clinical trials. - May 2016
Mark Lemmon on the underlying biochemistry of cancer. - April 2016
Roger Stupp on using alternating electric fields as treatment. - March 2016
Charlotte Vrinten on public perception of deaths from cancer. - February 2016
Guillermo Garcia-Manero on myelodysplastic syndromes (MDS). - December 2015/January 2016
Nazneen Rahman on germline genetic screening in ovarian cancer.
EJC News Focus – July/August 2012
Is oncology the right choice for you?
What combines research opportunities, intellectual challenge, and international collaboration in the study of a disease which affects many organs of the body and all sectors of society? And demands that specialists from many different backgrounds work together to crack sometimes intractable problems? It is, of course, oncology. As a career choice, it’s demanding; it takes passion coupled with a willingness to put in the hours and to learn how to discuss death honestly and sensitively. But for the right person, it can be immensely rewarding.
So - is it for you? In this EJC News Focus, opinion leaders in oncology discuss what the specialty has to offer, the impending shortage of oncologists, and also – how those setting out can best position themselves in the early years of their career.